Ifp Advisors, Inc Stoke Therapeutics, Inc. Transaction History
Ifp Advisors, Inc
- $3.28 Billion
- Q2 2025
Number of Shares
0Holding current value
$0% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding STOK
# of Institutions
148Shares Held
57.5MCall Options Held
2.7KPut Options Held
57.4K-
Black Rock Inc. New York, NY5.41MShares$124 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.4MShares$124 Million18.16% of portfolio
-
Rtw Investments, LP New York, NY5.12MShares$117 Million0.89% of portfolio
-
Baker Bros. Advisors LP New York, NY4.63MShares$106 Million0.53% of portfolio
-
Redmile Group, LLC San Francisco, CA4.38MShares$100 Million6.04% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $901M
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...